Breaking News

WuXi Biologics Passes EMA GMP Inspection

Suzhou site clears regulatory hurdle with not critical findings

By: Contract Pharma

Contract Pharma Staff

WuXi Biologics (Suzhou) Co., Ltd. has successfully passed its first GMP inspection by the European Medicines Agency (EMA), with no critical findings. This is one of the largest biosafety testing laboratories globally providing critical testing support for the global biologics industry.   The comprehensive inspection included areas directly related to biosafety testing of a client’s product, as well as WuXi Biologics (Suzhou)’s entire quality system, management system, related instrumentation and...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters